Allison S. Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allison S. Cohen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Henry Charles Manning
Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
2 shared publications - A. McGarry Houghton
Fred Hutchinson Cancer Center 9 , Seattle, Washington
1 shared publication - Adrienne L. Lehnert
Department of Radiation Oncology, University of Washington, Seattle, WA, USA
1 shared publication - Alexandra Badea
Quantitative Imaging and Analysis Laboratories, Radiology Department, Duke University Medical Center, Durham, NC, USA
1 shared publication - Cristian T. Badea
Duke University Medical Center
1 shared publication - Daniel Carl Sullivan
Department of Radiology Duke University Medical Center Durham North Carolina USA
1 shared publication
Latest Publications
- Open Access
- 27 March 2023
- Published by MDPI AG in Tomography
- Vol. 9 (2) , 750-758
An Online Repository for Pre-Clinical Imaging Protocols (PIPs)
Providing method descriptions that are more detailed than currently available in typical peer reviewed journals has been identified as an actionable area for improvement. In the biochemical and cell biology space, this need has been met through the creation of new journals focused on detailed protocols and materials sourcing. However, this format is not well suited for capturing instrument validation, detailed imaging protocols, and extensive statistical analysis. Furthermore, the need for additional information must be counterbalanced by the additional time burden placed upon researchers who may be already overtasked. To address these competing issues, this white paper describes protocol templates for positron emission tomography (PET), X-ray computed tomography (CT), and magnetic resonance imaging (MRI) that can be leveraged by the broad community of quantitative imaging experts to write and self-publish protocols in protocols.io. Similar to the Structured Transparent Accessible Reproducible (STAR) or Journal of Visualized Experiments (JoVE) articles, authors are encouraged to publish peer reviewed papers and then to submit more detailed experimental protocols using this template to the online resource. Such protocols should be easy to use, readily accessible, readily searchable, considered open access, enable community feedback, editable, and citable by the author.
- 27 March 2023
- Published by MDPI AG in Tomography
- Vol. 9 (2) , 750-758
Open AccessAn Online Repository for Pre-Clinical Imaging Protocols (PIPs)
Providing method descriptions that are more detailed than currently available in typical peer reviewed journals has been identified as an actionable area for improvement. In the biochemical and cell biology space, this need has been met through the creation of new journals focused on detailed protocols and materials sourcing. However, this format is not well suited for capturing instrument validation, detailed imaging protocols, and extensive statistical analysis. Furthermore, the need for additional information must be counterbalanced by the additional time burden placed upon researchers who may be already overtasked. To address these competing issues, this white paper describes protocol templates for positron emission tomography (PET), X-ray computed tomography (CT), and magnetic resonance imaging (MRI) that can be leveraged by the broad community of quantitative imaging experts to write and self-publish protocols in protocols.io. Similar to the Structured Transparent Accessible Reproducible (STAR) or Journal of Visualized Experiments (JoVE) articles, authors are encouraged to publish peer reviewed papers and then to submit more detailed experimental protocols using this template to the online resource. Such protocols should be easy to use, readily accessible, readily searchable, considered open access, enable community feedback, editable, and citable by the author.
- Open Access
PET Oncological Radiopharmaceuticals: Current Status and Perspectives
Molecular imaging is the visual representation of biological processes that take place at the cellular or molecular level in living organisms. To date, molecular imaging plays an important role in the transition from conventional medical practice to precision medicine. Among all imaging modalities, positron emission tomography (PET) has great advantages in sensitivity and the ability to obtain absolute imaging quantification after corrections for photon attenuation and scattering. Due to the ability to label a host of unique molecules of biological interest, including endogenous, naturally occurring substrates and drug-like compounds, the role of PET has been well established in the field of molecular imaging. In this article, we provide an overview of the recent advances in the development of PET radiopharmaceuticals and their clinical applications in oncology.
Open AccessPET Oncological Radiopharmaceuticals: Current Status and Perspectives
Molecular imaging is the visual representation of biological processes that take place at the cellular or molecular level in living organisms. To date, molecular imaging plays an important role in the transition from conventional medical practice to precision medicine. Among all imaging modalities, positron emission tomography (PET) has great advantages in sensitivity and the ability to obtain absolute imaging quantification after corrections for photon attenuation and scattering. Due to the ability to label a host of unique molecules of biological interest, including endogenous, naturally occurring substrates and drug-like compounds, the role of PET has been well established in the field of molecular imaging. In this article, we provide an overview of the recent advances in the development of PET radiopharmaceuticals and their clinical applications in oncology.